Chemoinformaics analysis of Malvadin-3-O-Alpha-L-Galactoside
Molecular Weight | 487.481 | nRot | 6 |
Heavy Atom Molecular Weight | 460.265 | nRig | 24 |
Exact Molecular Weight | 487.16 | nRing | 4 |
Solubility: LogS | -3.567 | nHRing | 2 |
Solubility: LogP | 2.73 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 2 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
nHA | 9 | APOL | 67.7734 |
nHD | 6 | BPOL | 34.0306 |
QED | 0.284 |
Synth | 4.456 |
Natural Product Likeliness | 1.946 |
NR-PPAR-gamma | 0.865 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.951 |
HIA | 0.62 |
CACO-2 | -5.917 |
MDCK | 0.00000612 |
BBB | 0.09 |
PPB | 0.909879 |
VDSS | 1.021 |
FU | 0.107687 |
CYP1A2-inh | 0.053 |
CYP1A2-sub | 0.093 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.141 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.376 |
CYP2d6-inh | 0.037 |
CYP2d6-sub | 0.245 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.052 |
CL | 9.409 |
T12 | 0.635 |
hERG | 0.013 |
Ames | 0.69 |
ROA | 0.087 |
SkinSen | 0.027 |
Carcinogencity | 0.122 |
EI | 0.013 |
Respiratory | 0.072 |
NR-Aromatase | 0.916 |
Antiviral | Yes |
Prediction | 0.90679 |